MedTrace Logo

Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy

NCT01472107 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 69

Last updated 2022-10-12

No results posted yet for this study

Summary

The GIMEMA FOUNDATION promotes an observational (retrospective) study on number and outcome of pregnancy in childbearing age female patients treated with chemotherapy for APL. These patients were enrolled in studies AIDA0493, AIDA2000 and were in CR.

Conditions

  • Acute Promyelocytic Leukemia
  • Pregnancy

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Giogina SPECCHIA, Pr. · UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-07
Primary Completion
2019-06-14
Completion
2019-06-14

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01472107 on ClinicalTrials.gov